Atovaquone Patent Expiration
Atovaquone is Used for treating Pneumocystis carinii infections. It was first introduced by Glaxosmithkline Llc
Atovaquone Patents
Given below is the list of patents protecting Atovaquone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mepron |
US6649659 (Pediatric) | Atovaquone pharmaceutical compositions |
Jan 10, 2017
(Expired) | Glaxosmithkline Llc |
| Mepron | US6649659 | Atovaquone pharmaceutical compositions |
Jul 10, 2016
(Expired) | Glaxosmithkline Llc |
Atovaquone's Family Patents
Explore Our Curated Drug Screens
Atovaquone Generic API Manufacturers
Several generic applications have been filed for Atovaquone. The first generic version for Atovaquone was by Amneal Pharmaceuticals and was approved on Mar 18, 2014. And the latest generic version is by Pai Holdings Llc Dba Pharmaceutical Associates Inc And Dba Pai Pharma and was approved on Oct 25, 2021.
Given below is the list of companies who have filed for Atovaquone generic, along with the locations of their manufacturing plants worldwide.
1. ABHAI LLC
Abhai Llc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Abhai Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | May 31, 2019 |
2. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | Mar 18, 2014 |
3. APOTEX
Apotex Inc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Discontinued | ORAL | N/A | Oct 11, 2017 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
4. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | Mar 30, 2021 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | Apr 28, 2017 |
6. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | Nov 21, 2018 |
7. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | Oct 11, 2018 |
8. LUPIN LTD
Lupin Ltd has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | Sep 11, 2018 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
9. PAI HOLDINGS
Pai Holdings Llc Dba Pharmaceutical Associates Inc And Dba Pai Pharma has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Pai Holdings.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG/5ML | suspension | Prescription | ORAL | AB | Oct 25, 2021 |
Manufacturing Plant Locations New
Pai Holdings's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Pai Holdings as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||